Sleep Disorders Trial, Recruiting NCT07572526 Sponsor: NYU Langone Health Condition: Sleep Disorders
Back to Sleep Disorders

Sleep Disorders Trial, Recruiting

NCT07572526
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who can read and understand study materials written in English, confirmed by a standard reading test score above 85
  • People who score 18 or higher on a depression symptom questionnaire (called the MADRS-S) during the screening process
  • People who have been diagnosed with Major Depressive Disorder (a serious form of depression) confirmed by a clinician interview
  • People who are taking antidepressant medication only if their dose has stayed the same for at least 30 days before the screening period
  • People who have either a local doctor or healthcare provider responsible for their ongoing care and available to be contacted if needed, or who have confirmed knowledge of local support resources
  • People who are able to give informed consent and follow the study procedures
  • People who have access to a quiet space at home suitable for brain stimulation sessions

Who may not be able to join:

  • People with a significant ongoing medical condition that, in the opinion of the study clinician, could interfere with participation, safety, or the study results
  • People with a current or past diagnosis of bipolar disorder or a psychotic disorder, or who have had an alcohol or substance use disorder in the past 6 months, as determined during the screening interview
  • People with serious thoughts of suicide or suicidal behaviour, based on clinician assessment and a formal rating scale
  • People who have used prescription or over-the-counter sleep medications, or started a sleep-focused therapy programme, in the 30 days before screening
  • People with a history of seizures or epilepsy
  • People who have an active implanted medical device located above the neck (such as a deep brain stimulator or cochlear implant), or metal implants in the head or neck area that are not compatible with MRI
  • People who are currently using any prescription or over-the-counter sleep medications, or are actively taking part in any treatment specifically aimed at improving sleep
  • People who are currently pregnant, planning to become pregnant during the study, or who are breastfeeding — people who could become pregnant would be required to use an accepted form of contraception throughout the study (confirm with trial site for full details)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Giuseppina Pilloni, NYU Langone Health

Phone: 929-455-5104

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
4 June 2026
Est. completion
30 November 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Change in sleep efficiency

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov